Frequently Asked Questions
North America dominates the biobanking market because of the continuous investment in the collection, establishment, and processing of large-scale datasets within the regions.
The growth rate of the biobanking market is 6.10%.
The increase in genomic research activities for studying diseases across the globe is the growth driver of the biobanking market.
Product and services, sample type, storage type, type of biobank, ownership and application are the factors on which the biobanking market research is based.
Major companies in the biobanking market are Thermo Fisher Scientific Inc, Tecan Trading AG, QIAGEN, Hamilton Company., Brooks Life Sciences, TTP Labtech, VWR International, LLC, Promega Corporation, Worthington Industries, BD, Merck KGaA, Biokryo GmbH, Cell&Co BioServices, RUCDR Infinite Biologics, Modul-Bio, STEMCELL Technologies Inc, BioLifeSolutions Inc., BioCision., and Taylor-Wharton., among others.
